Seminar of the week: Subhabrata Sen, Blue LED induced synthesis of natural product inspired scaffolds and their application as anticancer agents
Published on
Subhabrata Sen is visiting Ralf Jockers' team until 15 May 2022, to collaborate on new treatments for Covid-19. He is open to discussion during his stay. His studies aim at developing novel drugs using multi-targeted therapy approaches by molecular screening using complementary competencies in molecular biology (Jockers’ team approach) and synthetic organic/ medicinal chemistry.
